PDCD1 and osteosarcoma: Thus, inhibiting PD-1/PD-L1 could be an interesting approach capable of restoring the function of the immune system against osteosarcoma cells (Koirala et al., 2016[27]; Shen et al., 2014[55]; Wang et al., 2016[67]).